Apton Biosystems Appoints John W. Hanna as Chief Executive Officer and Board Director
PLEASANTON, Calif., June 2, 2021 /PRNewswire-PRWeb/ -- Apton Biosystems, Inc., a developer of Super-Res sequencing instruments for large-scale clinical applications such as early cancer detection and population sequencing, today announced the appointment of John W. Hanna as chief executive officer and board director.
- PLEASANTON, Calif., June 2, 2021 /PRNewswire-PRWeb/ -- Apton Biosystems, Inc., a developer of Super-Res sequencing instruments for large-scale clinical applications such as early cancer detection and population sequencing, today announced the appointment of John W. Hanna as chief executive officer and board director.
- Prior to that, Mr. Hanna held sales and business development roles at IBM, Humana, Inc, and America's Health Insurance Plans (AHIP).
- "Apton is at a critical inflection point as it enters into the commercialization phase of the company," said Heiner Dreismann, Apton's board chairman.
- "I could not be more pleased to have an exceptional and proven executive in John providing the leadership needed as we prepare for growth."